The use of Urovysion™ fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder-Reference-Cited by-同舟云学术

The use of Urovysion™ fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder

Published:2008-10-31 Issue:1 Volume:22 Page:119-127
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Reid-Nicholson Michelle D,Ramalingam Preetha,Adeagbo Bamidele,Cheng Ningli,Peiper Stephen C,Terris Martha K

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2008179.pdf

Reference34 articles.

1. Lopez-Beltran A, Sauter G, Gasser T, et al. Infiltrating urothelial carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital System, 1st edn. IARC Press: Lyon, France, 2004, pp 93–109.

2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43–66.

3. Kakizoe T . Development and progression of urothelial carcinoma. Cancer Sci 2006;97:821–828.

4. Grignon DJ, El-Bolkainy M, Schimitz-Drager BJ, et al. Squamous cell carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital System, 1st edn. IARC Press: Lyon, France, 2004, pp 124–129.

5. Guo CC, Fine SW, Epstein JI . Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Am J Surg Pathol 2006;30:883–891.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fish: A Promising Screening Tool for Malignancy after Augmentation Cystoplasty?;Journal of Pediatric Surgery;2023-11

2. UroVysion™ fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages;Frontiers in Molecular Biosciences;2023-10-05

3. Efficacy and safety of transurethral resection of bladder tumour combined with chemotherapy and immunotherapy in bladder-sparing therapy in patients with T1 high-grade or T2 bladder cancer: a protocol for a randomized controlled trial;BMC Cancer;2023-04-06

4. Molecular Pathology of Kidney Tumors;Molecular Surgical Pathology;2023

5. UroVysionTM Fluorescence In Situ Hybridization in Urological Cancers: A Narrative Review and Future Perspectives;Cancers;2022-11-03